Article
MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease.
Inflammatory bowel diseases - 1 May 2007
Mendoza Juan L, Urcelay Elena, Lana Raquel, Martín M Carmen, López Natalia, Guijarro Luis G, Mayol Julio A, Taxonera Carlos, de la Concha Emilio G, Peña Amado S, Díaz-Rubio Manuel
Abstract excerpt
BACKGROUND: To investigate the contribution of multidrug resistance 1 (MDR1) gene pharmacogenetics (G2677T/A and C3435T) to the efficacy of azathioprine in inducing remission in patients with Crohn's disease (CD). METHODS: A cohort of 327 unrelated Spanish patients with CD recruited from a single center was studied. All patients were rigorously followed up for at least 2 years (mean time, 11.5 years). A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
